
A drawing from Radiation Stabilization Solutions’ patent.
Radiotherapy systems maker Accuray (NSDQ:ARAY) settled a patent infringement beef with Radiation Stabilization Solutions this month, agreeing to pay $150,000 to resolve all outstanding claims.
Sunnyvale, Calf.-based Accuray unveiled it its latest regulatory filing that it had closed a year-old claim wedged by Radiation Stabilization Solutions over a patent describing a "stabilizing system, which is especially useful in radiation therapy."
RSS lodged the complaint for in September 2011, initially including a clutch of other alleged infringers, including Varian Medical Systems (NYSE:VAR), Elekta (STO:EKTA B) and others, according to a regulatory filing.
That lawsuit was dismissed a month later when a judge for the U.S. District Court for the Northern District of Illinois’ Eastern Division determined that RSS had inappropriately included "non-resident" defendants.
RSS re-filed separate suits against Accuray and the other defendants, repeating the original allegations and seeking damages for patent infringement.
Accuray asked the court to dismiss the cast and in August 2012 the company landed a partial win, with the court sending RSS back to amend its complaint. RSS filed a new complaint in September, and early this month the companies came to an agreement to settle the case.
Accuray did not specify when the payment would be made.
Accuray recently announced a leadership swap, replacing former CEO Euan Thomson with Joshua Levine, the former CEO of Mentor Corp. and Immucor.
Thomson, who led held the corner office since 2002, said in a prepared statement that a change in the company’s leadership was "healthy for the organization."